SB 1023: Health care coverage: antiretroviral drugs, drug devices, and drug products.

The bill would prohibit health care service plans and health insurers from subjecting antiretroviral drugs to prior authorization or step therapy for HIV/AIDS prevention. It would require coverage of non-self-administered antiretroviral drugs approved by the FDA for HIV/AIDS prevention as a medical benefit. The bill would also make a willful violation of these provisions a crime, requiring reimbursement by the state for the costs incurred. However, no reimbursement would be required if the non-compliance is due to a lack of authority from the state.